All News #Library
FDA Issues Form 483 to Takeda Pharmaceutical
15 Nov 2024 //
FDA
FDA Issues Form 483 to Takeda Pharmaceutical Company Limited
24 Sep 2024 //
FDA
Takeda Pharmaceutical Company on Health Canada Inspection List
23 Dec 2020 //
HEALTH CANADA
Takeda Pharmaceutical Company Receives FDA Warning Letter
17 Jun 2020 //
FDA
Health Canada Issues Recall of Teijin Limited ULORIC ® (febuxostat)
05 Nov 2019 //
HEALTH CANADA
Takeda Issues US Recall of NATPARA® (parathyroid hormone)
06 Sep 2019 //
FDA
Enforcement Report - Week of November 21, 2018
21 Nov 2018 //
FDA
Enforcement Report - Week of October 17, 2018
17 Oct 2018 //
FDA

Market Place
Sourcing Support